InBiomics.com

InBiomics is a deep-tech biotech venture developing a human microglia–based biosensing platform to functionally measure neuroinflammation from patient-derived extracellular vesicles (EVs). By combining advanced cell culture systems, high-content imaging, and machine learning analytics, InBiomics transforms circulating biological signals into quantitative inflammatory response profiles. The platform enables drug screening, biomarker discovery, and patient stratification in neuropsychiatric and neurodegenerative diseases. By replacing low-predictive animal models with scalable human-relevant assays, InBiomics accelerates translational research and provides pharma with reproducible, mechanism-anchored potency metrics.